The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer.
 
Helen J. Ross
Research Funding - Abbvie (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Spectrum Pharmaceuticals (Inst)
 
Chen Hu
Consulting or Advisory Role - Merck Sharp & Dohme
 
Kristin Ann Higgins
Consulting or Advisory Role - AstraZeneca; Genentech; Varian Medical Systems
Speakers' Bureau - AstraZeneca
Research Funding - Reflexion Medical
 
Salma K. Jabbour
Consulting or Advisory Role - Merck Sharp & Dohme
Research Funding - Merck Sharp & Dohme (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
David E. Kozono
No Relationships to Disclose
 
Taofeek Kunle Owonikoko
Stock and Other Ownership Interests - CAMBIUM MEDICAL TECHNOLOGIES
Consulting or Advisory Role - Abbvie; Amgen; ARMO BioSciences; AstraZeneca; Bayer; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Eisai; EMD Serono; G1 Therapeutics; HERON; Lilly; Lilly; MedImmune; Merck; Novartis; PharmaMar; Sandoz; Seagen; Takeda; Xcovery
Speakers' Bureau - Abbvie
Research Funding - Abbvie (Inst); Aeglea Biotherapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Corvus Pharmaceuticals; Fujifilm (Inst); G1 Therapeutics (Inst); Incyte (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Stem CentRx (Inst); United Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - DR4 Modulation and its Implications in EGFR-Target Cancer Therapy Ref:18089 PROV (CSP) United States Patent Application No. 62/670,210 June 26, 2018 (Co-Inventor) (Inst); OVERCOMING ACQUIRED RESISTANCE TO CHEMOTHERAPY TREATMENTS THROUGH SUPPRESSION OF STAT3 (Inst); SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO (Inst); Soluble FAS ligand as a biomarker of recurrence in thyroid cancer; provisional patent 61/727,519 (Inventor) (Inst)
Other Relationship - EMD Serono; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Reflexion Medical
 
Benjamin Movsas
Honoraria - Viewray
Speakers' Bureau - Viewray
Research Funding - Philips Healthcare (Inst); Varian Medical Systems (Inst); ViewRay (Inst)
Patents, Royalties, Other Intellectual Property - Lung phantom for image guidance; MR-CT imaging related patent for radiation oncology
Travel, Accommodations, Expenses - Varian Medical Systems
 
Timothy Solberg
No Relationships to Disclose
 
Canhua Xiao
No Relationships to Disclose
 
Terence Marques Williams
No Relationships to Disclose
 
James William Welsh
Employment - MD Anderson Cancer Center; MD Anderson Cancer Center
Leadership - MolecularMatch; MolecularMatch
Stock and Other Ownership Interests - Alpine Immune Sciences; Checkmate Pharmaceuticals; Mavupharma; MolecularMatch; Nanobiotix; Nanorobotix; Oncorena; Reflexion Medical; Reflexion Medical
Honoraria - Aileron Therapeutics; American Association of Physicists in Medicine; Nanobiotix; Reflexion Medical; Shandong Cancer Hospital; The Korean Society for Radiation Oncology
Consulting or Advisory Role - Alpine Immune Sciences; AstraZeneca; Checkmate Pharmaceuticals; Legion Healthcare Partners; Mavu Pharmaceutical; MolecularMatch; Oncorena; Reflexion Medical
Research Funding - Aileron Therapeutics; Bristol-Myers Squibb; Checkmate Pharmaceuticals; Checkmate Pharmaceuticals; Mavu Pharmaceutical; Merck; Nanobiotix
Patents, Royalties, Other Intellectual Property - MolecularMatch
Travel, Accommodations, Expenses - AACR; Aileron Therapeutics; American Society for Radiation Oncology; Gustave Roussy Cancer Center; IASLC; MedAustron; Nanobiotix; Radiation Research Society; Reflexion Medical; Shandong Cancer Hospital; The Korean Society for Radiation Oncology; The Korean Society for Radiation Oncology; The Korean Society for Radiation Oncology; Turkish Society of Lung Cancer
 
Jeffry Simko
No Relationships to Disclose
 
Xiaofei F. Wang
No Relationships to Disclose
 
Nisha Anjali Mohindra
Consulting or Advisory Role - Bristol-Myers Squibb; Guardant Health
Research Funding - Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Charles Hsu
No Relationships to Disclose
 
Tom Stinchcombe
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; EMD Serono; Foundation Medicine; G1 Therapeutics; Genentech/Roche; Lilly; Novartis; Pfizer; Takeda
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Genentech/Roche (Inst); Merck (Inst); Regeneron (Inst); Takeda (Inst)
 
Jeffrey Bradley
Consulting or Advisory Role - AstraZeneca